mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.3 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.3 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |